PITER collaborating group. Forecasting Hepatitis C liver disease burden on real life data. Does the hidden iceberg matter to reach the elimination goals?

Autor: Kondili, La, Robbins, S, Blach, S, Gamkrelidze, I, Zignego, Al, Brunetto, Mr, Raimondo, G, Taliani, G, Iannone, A, Russo, Fp, Santantonio, Ta, Zuin, M, Chessa, L, Blanc, P, Puoti, M, Vinci, M, Erne, Em, Strazzabosco, M, Massari, M, Lampertico, P, Rumi, Mg, Federico, A, Orlandini, A, Ciancio, A, Borgia, G, Andreone, P, Caporaso, N, Persico, M, Ieluzzi, D, Madonia, S, Gori, A, Gasbarrini, A, Coppola, C, Brancaccio, G, Andriulli, A, Quaranta, Mg, Montilla, S, Razavi, H, Melazzini, M, Vella, S, Craxì, A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3728::74cff0c7a8fdd0935336a8c989051e4e
http://hdl.handle.net/11568/925510

Tenofovir Alafenamide improves proximal tubular markers in CHB patients long-term treated with Tenofovir Disoproxil Fumarate: A real-life study based on the EASL switching criteria

Autor: Loglio, A., Viganò, M., Borghi, M., Gentile, C., Facchetti, F., Sambarino, D., Perbellini, R., Soffredini, R., Renteria, SC. Uceda, Rumi, MG., Lampertico, P.

Publikováno v: In Digestive and Liver Disease March 2021 53 Supplement 1:S14-S14

Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting

Autor: Prati, D, Gasbarrini, A, Mazzotta, F, Sagnelli, E, Carosi, G, Abrescia, N, Alberti, Alfredo, Ambu, S, Andreone, P, Andriulli, A, Angelico, M, Antonucci, G, Ascione, A, Belli, Ls, Bruno, R, Bruno, S, Burra, Patrizia, Camma, C, Caporaso, N, Cariti, G, Cillo, U, Coppola, N, Craxi, A, DE LUCA, A, DE MARTIN, E, DI MARCO, V, Fagiuoli, S, Ferrari, C, Gaeta, Gb, Galli, M, Grieco, A, Grossi, P, Licata, A, Maida, I, Mangia, A, Marino, N, Maserati, R, Missale, G, Mondelli, M, Nasta, P, Niro, G, Persico, M, Petrelli, E, Picciotto, A, Piscaglia, F, Pollicino, T, Puoti, C, Puoti, M, Raimondo, G, Rumi, Mg, Santantonio, T, Smedile, A, Squadrito, G, Baroni, Gs, Taliani, G, Tavio, M, Toti, M, Bonino, F, Brunetto, Mr, Cacopardo, B, Caremani, M, Cauda, R, Colombo, M, DI PERRI, G, Donato, F, Farci, P, Fattovich, G, Filice, G, Ghinelli, F, Guadagnino, V, Lazzarin, A, Levrero, M, Licata, G, Orani, A, Paffetti, A, Pastore, G, Piccinino, F, Pizzigallo, E, Pontisso, Patrizia, Portelli, V, Rizzetto, M, Rossi, A, Stroffolini, T, Ubaldi, E, Santantanio, T, Alberti, A., Antonucci, Gf, Craxi, A.

It is increasingly clear that a tailored therapeutic approach to patients with hepatitis C virus infection is needed. Success rates in difficult to treat and low-responsive hepatitis C virus patients are not completely satisfactory, and there is the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cab98eb53e5891ee8875467bbc0a2da3
http://hdl.handle.net/11386/4270261

Hepatitis C virus/human immunodeficiency virus coinfection inhemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy

Autor: Mancuso, Me, Rumi, Mg, Aghemo, A, Santagostino, E, Puoti, Massimo, Coppola, A, Colombo, M, Mannucci, P. M.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3662::569a52d9f141abcaa0719bdb42dc03d1
http://hdl.handle.net/11379/35477

Hepatitis C is more severe in drug users with human immunodeficiency virus infection

Autor: Romeo, R, Rumi, Mg, Donato, Mf, Cargnel, Ma, Vigano, P, Mondelli, M, Cesana, Bruno Mario, Colombo, M.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3662::07dc7d93f5bdd140d15e81e955f383d9
http://hdl.handle.net/11379/37078